FWIW, SGEN has one of my companies' mAbs in an ADC clinical program at the moment. Hopefully, the target of the program proves vulnerable to its mAb (and, hopefully, the program itself survives the PFE closing).
“It is possible to be a normal decent person and yet to be fully alive.” - George Orwell
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.